Research Article | Open Access
Volume 2022 - 1 | Article ID 209 | https://dx.doi.org/10.51521/IJGHE.2022.1102
Academic Editor: John Bose
KATHERESAN V1, KESAVAN B2, PONCHIDAMBARAM M2,
PRAKASHEN OK3, SIVASANKAR A*
1M.ch Resident,
Department of Surgical Gastroenterology, Government Mohan Kumaramangalam
Medical College and Hospital, Salem, TamilNadu, Email: kaddy7375@gmail.com; kesav_92@yahoo.co.in
2Associate
Professor, Department of Surgical Gastroenterology, Government Mohan
Kumaramangalam Medical College and Hospital, Salem, TamilNadu, Email: drponchi@gmail.com
3Assistant
Professor, Department of Surgical Gastroenterology, Government Mohan
Kumaramangalam Medical College and Hospital, Salem, TamilNadu, Email: prakashen.ok@gmail.com
*Corresponding author: Dr Sivasankar A M.ch., Professor and the Head
of the Department, Department of Surgical Gastroenterology, Government Mohan
Kumaramangalam Medical College and Hospital, Salem, TamilNadu, Email: gastrocon2020@gmail.com
Citation: Katheresan
V, Kesavan B, Ponchidambaram M0, Prakashen OK, Sivasankar A*, (2022)
Clinicopathological Trends of Colorectal Carcinoma Patients in a Tertiary Care
Centre in South India. Int J Gastroenterol Hepatol Endosc, 1(1);1-5.
Copyright: © 2022, Sivasankar
A*. This is an open-access article distributed under the terms of the
Creative Commons Attribution 4.0 International License, which permits
unrestricted use, distribution and reproduction in any medium, provided the
original author and source are credited.
ABSTRACT:
Background: Cancer is attributed to 10 million deaths worldwide in 2020. One
in six deaths is due to Cancer. colorectal carcinoma ranked third contributing
1.93 million cases while deaths due to it stood second contributing 916000 next
to lung cancer. The sustainable development goal 3 emphasizes on “Ensuring
healthy lives and promote well-being for all at all ages”. Regular screening is
the process of detecting colorectal cancer in patients with no symptoms. The
treatment for colorectal carcinoma is surgical removal of primary tumor,
adjuvant chemotherapy and palliative radiotherapy. Methodology: We
reviewed data of colorectal carcinoma operated patients retrospectively for
three consecutive years in a tertiary care centre in the South Indian State,
Tamil Nadu (2018, 2019 & 2020). There were about 336 participants enrolled
for the study. Their medical records were reviewed for data collection. Data
collection was done by trained Senior Resident Doctors posted in the Department
of Surgical Gastroenterology. Results: The study found that
the colorectal carcinoma is highly prevalent in the 40 – 60 years age group. It
is predominant among male. The most common anatomical location being rectum,
rectosigmoid junction, right colon and sigmoid colon. The most common symptoms
at presentation were anorexia, bleeding, constipation, altered bowel habits and
weight loss. Well differentiated adenocarcinoma was the most common
histopathological type in all the three years. Recommendations: The
screening for the same can be done at a young age of 30 years itself as we do
for other non-communicable diseases like systemic hypertension and diabetes.
The symptoms at presentation ought to be explained in health education sessions
to improve the general awareness of the public.
KEYWORDS: colorectal carcinoma, histopathological trends, trends in colorectal
carcinoma, gastrointestinal tumours.
INTRODUCTION
Cancer is attributed to 10 million deaths worldwide in 2020. One in six
deaths is due to Cancer [1]. Neoplasms/ tumors are abnormal growth of
cells. They may be benign or malignant. Generally, benign tumors are slow
growing and can’t spread to other tissues whereas malignant tumors grow rapidly
and can spread to other organs known as metastasis. Incident cases of cancer
account for 18.1 million cases universally in 2018 and is expected to rise to
29.4 million cases by 2040. Depending on the incidence of new cancer cases,
colorectal carcinoma ranked third contributing 1.93 million cases while deaths due
to it stood second contributing 916000 next to lung cancer [2]. The first
target as per the WHO action plan for prevention and control of
non-communicable diseases (2013 – 2020) is 25% reduction in overall mortality
due to the major non-communicable diseases like cardiovascular diseases,
diabetes, cancers and chronic respiratory diseases [3]. The sustainable
development goal 3 emphasizes on “Ensuring healthy lives and promote well-being
for all at all ages”. One of the indicators urges us to reduce mortality from
NCD’s and promote mental health [4]. This is also in line with the WHO action
plan for control of non-communicable diseases.
Genetic and environmental risk factors contribute to the development of
colorectal carcinoma. The risk doubles if a first degree relative is diagnosed
with colorectal cancer when his age is greater than 70 years. The risk triples
if his age is less than 50 years when diagnosed [5].
Acquired risk factors include diet, lifestyle, side effects of medical
interventions and medical co-morbidities. Diet includes reduced consumption of
fruits, vegetables, dietary fibre and increased intake of red meat and
saturated fats. Drinking coffee and alcohol adds to the risk. Lifestyle
comprises sedentary lifestyle and smoking [6]. Most cancers of the colon start
as a polyp. These are over growth of the cells on the inner walls of the colon.
These are called adenomas which are non-cancerous and may take long time to
develop into an invasive colon carcinoma. These adenomas can be removed surgically
during a colonoscopy called polypectomy [7].
Regular screening is the process of detecting colorectal cancer in
patients with no symptoms. This can eventually prevent colorectal cancer. The
five-year survival rate for detection at an early stage is 90% for colorectal
carcinoma [8].
The treatment for colorectal carcinoma is surgical removal of primary
tumor, adjuvant chemotherapy and palliative radiotherapy [9]. Nowadays,
endoscopic removal practices are also available which is entirely based on the
stage and severity of the illness [10].